TRDA Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. (TRDA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $1.4M.
Where they traded
Last open-market purchase: May 20, 2026 , by Zeiher Bernhardt G .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| 2 fills | Sell | 57,674 | $7.13 | $411.2K | 3,885,115 −1.5% of holding | ||
| 2 fills | Sell | 385,000 | $7.41 | $2.9M | 3,913,952 −9% of holding | ||
| 2 fills | Sell | 77,000 | $7.11 | $547.5K | 4,106,452 −1.8% of holding | ||
| 2 fills | Sell | 64,526 | $7.17 | $462.7K | 4,144,952 −1.5% of holding | ||
| 2 fills | Sell | 50,262 | $7.19 | $361.4K | 4,177,215 −1.2% of holding | ||
| 2 fills | Sell | 58,176 | $7.06 | $410.7K | 4,202,346 −1.4% of holding | ||
| 2 fills | Sell | 88,518 | $6.99 | $618.7K | 4,231,434 −2% of holding | ||
| 2 fills | Sell | 7,466 | $7.01 | $52.3K | 4,275,693 −0.2% of holding | ||
| 2 fills | Sell | 77,844 | $7.20 | $560.5K | 4,279,426 −1.8% of holding | ||
| 2 fills | Sell | 29,138 | $7.06 | $205.7K | 4,318,348 −0.7% of holding | ||
| 2 fills | Sell | 53,044 | $7.54 | $400.0K | 4,332,917 −1.2% of holding | ||
| 2 fills | Sell | 43,246 | $7.34 | $317.4K | 4,359,439 −1% of holding | ||
| PARMAR KUSH | Director | Sell | 92,444 | $7.00 | $647.1K | 2,691,337 −3.3% of holding | |
| Sell | 52,317 | $6.85 | $358.4K | 2,783,781 −1.8% of holding | |||
| PARMAR KUSH | Director | Sell | 52,317 | $6.85 | $358.4K | 2,783,781 −1.8% of holding | |
| Sell | 10,494 | $7.00 | $73.5K | 2,836,098 −0.4% of holding | |||
| PARMAR KUSH | Director | Sell | 10,494 | $7.00 | $73.5K | 2,836,098 −0.4% of holding | |
| Sell | 1,718 | $6.85 | $11.8K | 2,846,592 −0.1% of holding | |||
| PARMAR KUSH | Director | Sell | 1,718 | $6.85 | $11.8K | 2,846,592 −0.1% of holding | |
| Sell | 114,756 | $6.93 | $795.3K | 2,848,310 −3.9% of holding | |||
| PARMAR KUSH | Director | Sell | 114,756 | $6.93 | $795.3K | 2,848,310 −3.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.